Gene expression analysis of rheumatoid arthritis synovial lining regions by cDNA microarray combined with laser microdissection: up-regulation of inflammation-associated STAT1, IRF1, CXCL9, CXCL10, and CCL5

References

• Gay S, Gay RE, Koopman WJ. Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction? Ann Rheum Dis 1993;52(Suppl 1):S39–47.
   Google Scholar
• Noss EH, Brenner MB. The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis. Immunol Rev 2008;223:252–70.
   PubMed Web of Science ®Google Scholar
• Iwamoto T, Okamoto H, Toyama Y, Momohara S. Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients. FEBS J 2008;275:4448–55.
   PubMed Web of Science ®Google Scholar
• Yokota K, Miyazaki T, Hirano M, Akiyama Y, Mimura T. Simvastatin inhibits production of interleukin 6 (IL-6) and IL-8 and cell proliferation induced by tumor necrosis factor-alpha in fibroblast-like synoviocytes from patients with rheumatoid arthritis. J Rheumatol 2006;33:463–71.
   PubMed Web of Science ®Google Scholar
• van der Pouw Kraan TC, van Gaalen FA, Kasperkovitz PV, Verbeet NL, Smeets TJ, Kraan MC, . Rheumatoid arthritis is a heterogeneous disease: evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues. Arthritis Rheum 2003;48:2132–45.
   PubMed Web of Science ®Google Scholar
• Ivashkiv LB, Hu X. The JAK/STAT pathway in rheumatoid arthritis: pathogenic or protective? Arthritis Rheum 2003;48:2092–6.
   PubMedGoogle Scholar
• Kasperkovitz PV, Verbeet NL, Smeets TJ, van Rietschoten JG, Kraan MC, van der Pouw Kraan TC, . Activation of the STAT1 pathway in rheumatoid arthritis. Ann Rheum Dis 2004; 63:233–9.
   PubMed Web of Science ®Google Scholar
• Yarilina A, Park-Min KH, Antoniv T, Hu X, Ivashkiv LB. TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes. Nat Immunol 2008;9:378–87.
   PubMed Web of Science ®Google Scholar
• Bromberg J, Darnell JE Jr. The role of STATs in transcriptional control and their impact on cellular function. Oncogene 2000;19: 2468–73.
   PubMed Web of Science ®Google Scholar
• Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, . IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 2001; 410:1107–11.
   PubMed Web of Science ®Google Scholar
• Gerard C, Rollins BJ. Chemokines and disease. Nat Immunol 2001;2:108–15.
   PubMed Web of Science ®Google Scholar
• Kunkel SL, Lukacs N, Kasama T, Strieter RM. The role of chemokines in inflammatory joint disease. J Leukoc Biol 1996;59:6–12.
   PubMed Web of Science ®Google Scholar
• Jenkins JK, Hardy KJ, McMurray RW. The pathogenesis of rheumatoid arthritis: a guide to therapy. Am J Med Sci 2002;323: 171–80.
   PubMed Web of Science ®Google Scholar
• Haringman JJ, Ludikhuize J, Tak PP. Chemokines in joint disease: the key to inflammation? Ann Rheum Dis 2004;63:1186–94.
   PubMed Web of Science ®Google Scholar
• Chen X, Oppenheim JJ, Howard OM. Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): inhibitory effects of traditional Chinese medicinal components. Cell Mol Immunol 2004;1:336–42.
   PubMedGoogle Scholar
• Szekanecz Z, Szucs G, Szanto S, Koch AE. Chemokines in rheumatic diseases. Curr Drug Targets 2006;7:91–102.
   PubMed Web of Science ®Google Scholar
• Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, . Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999;286:531–7.
   PubMed Web of Science ®Google Scholar
• DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, . Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 1996;14:457–60.
   PubMed Web of Science ®Google Scholar
• Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, . Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 2000;24:227–35.
   PubMed Web of Science ®Google Scholar
• Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, . Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503–11.
   PubMed Web of Science ®Google Scholar
• Perou CM, Jeffrey SS, van de Rijn M, Rees CA, Eisen MB, Ross DT, . Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci USA 1999;96:9212–17.
   PubMed Web of Science ®Google Scholar
• Heller RA, Schena M, Chai A, Shalon D, Bedilion T, Gilmore J, . Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc Natl Acad Sci USA 1997;94:2150–5.
   PubMed Web of Science ®Google Scholar
• Zanders ED, Goulden MG, Kennedy TC, Kempsell KE. Analysis of immune system gene expression in small rheumatoid arthritis biopsies using a combination of subtractive hybridization and high-density cDNA arrays. J Immunol Methods 2000;233:131–40.
   PubMedGoogle Scholar
• Ungethuem U, Haeupl T, Witt H, Koczan D, Krenn V, Huber H, . Molecular signatures and new candidates to target the pathogenesis of rheumatoid arthritis. Physiol Genomics 2010;42A:267–82.
   PubMed Web of Science ®Google Scholar
• Schena M, Shalon D, Heller R, Chai A, Brown PO, Davis RW. Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci USA 1996;93: 10614–19.
   PubMed Web of Science ®Google Scholar
• Kikuchi T, Daigo Y, Katagiri T, Tsunoda T, Okada K, Kakiuchi S, . Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs. Oncogene 2003;22:2192–205.
   PubMed Web of Science ®Google Scholar
• He P, Varticovski L, Bowman ED, Fukuoka J, Welsh JA, Miura K, . Identification of carboxypeptidase E and gamma-glutamyl hydrolase as biomarkers for pulmonary neuroendocrine tumors by cDNA microarray. Hum Pathol 2004;35:1196–209.
   PubMedGoogle Scholar
• Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F. The American College of Rheumatology 1991 revised critria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 1992;35:498–502.
   PubMed Web of Science ®Google Scholar
• Krenn V, Morawietz L, Burmester GR, Haupl T. [Synovialitis score: histopathological grading system for chronic rheumatic and non-rheumatic synovialitis], in German. Z Rheumatol 2005;64: 334–42.
   PubMed Web of Science ®Google Scholar
• Rubin MA. Use of laser capture microdissection, cDNA microarrays, and tissue microarrays in advancing our understanding of prostate cancer. J Pathol 2001;195:80–6.
   PubMed Web of Science ®Google Scholar
• Tsubaki T, Arita N, Kawakami T, Shiratsuchi T, Yamamoto H, Takubo N, . Characterization of histopathology and gene-expression profiles of synovitis in early rheumatoid arthritis using targeted biopsy specimens. Arthritis Res Ther 2005;7:R825–36.
   PubMedGoogle Scholar
• Lin SM, Du P, Huber W, Kibbe WA. Model-based variance-stabilizing transformation for Illumina microarray data. Nucleic Acids Res 2008;36:e11.
   PubMed Web of Science ®Google Scholar
• Du P, Kibbe WA, Lin SM. lumi: a pipeline for processing Illumina microarray. Bioinformatics 2008;24:1547–8.
   PubMed Web of Science ®Google Scholar
• Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001;98:5116–21.
   PubMed Web of Science ®Google Scholar
• Ohshima K, Kawasaki C, Muta H, Muta K, Deyev V, Haraoka S, . CD10 and Bcl10 expression in diffuse large B-cell lymphoma: CD10 is a marker of improved prognosis. Histopathology 2001;39:156–62.
   PubMed Web of Science ®Google Scholar
• Decker T, Kovarik P. Serine phosphorylation of STATs. Oncogene 2000;19:2628–37.
   PubMed Web of Science ®Google Scholar
• Pilz A, Ramsauer K, Heidari H, Leitges M, Kovarik P, Decker T. Phosphorylation of the Stat1 transactivating domain is required for the response to type I interferons. EMBO Rep 2003;4:368–73.
   Google Scholar
• Nishioka K, Hasunuma T, Kato T, Sumida T, Kobata T. Apoptosis in rheumatoid arthritis: a novel pathway in the regulation of synovial tissue. Arthritis Rheum 1998;41:1–9.
   PubMedGoogle Scholar
• Hasunuma T, Kato T, Kobata T, Nishioka K. Molecular mechanism of immune response, synovial proliferation and apoptosis in rheumatoid arthritis. Springer Semin Immunopathol 1998;20:41–52.
   PubMedGoogle Scholar
• Yoshida S, Higuchi F, Ishibashi Y, Goto M, Sugita Y, Nomura Y, . Downregulation of RCAS1 and upregulation of cytotoxic T cells affects synovial proliferation and apoptosis in rheumatoid arthritis. J Rheumatol 2008;35:1716–22.
   PubMedGoogle Scholar
• Tak PP. IFN-beta in rheumatoid arthritis. Front Biosci 2004;9: 3242–7.
   PubMed Web of Science ®Google Scholar
• van Holten J, Smeets TJ, Blankert P, Tak PP. Expression of interferon beta in synovial tissue from patients with rheumatoid arthritis: comparison with patients with osteoarthritis and reactive arthritis. Ann Rheum Dis 2005;64:1780–2.
   PubMed Web of Science ®Google Scholar
• Gardam MA, Keystone EC, Menzies R, Manners S, Skamene E, Long R, . Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect Dis 2003;3:148–55.
   PubMed Web of Science ®Google Scholar
• Antoni C, Braun J. Side effects of anti-TNF therapy: current knowledge. Clin Exp Rheumatol 2002;20:S152–7.
   PubMed Web of Science ®Google Scholar
• Shiraishi A, Dudler J, Lotz M. The role of IFN regulatory factor-1 in synovitis and nitric oxide production. J Immunol 1997;159: 3549–54.
   PubMedGoogle Scholar
• Kunkel SL. Through the looking glass: the diverse in vivo activities of chemokines. J Clin Invest 1999;104:1333–4.
   PubMedGoogle Scholar
• Murdoch C, Finn A. Chemokine receptors and their role in inflammation and infectious diseases. Blood 2000;95:3032–43.
   PubMed Web of Science ®Google Scholar
• Kuan WP, Tam LS, Wong CK, Ko FW, Li T, Zhu T, . CXCL 9 and CXCL 10 as sensitive markers of disease activity in patients with rheumatoid arthritis. J Rheumatol 2010;37: 257–64.
   Google Scholar
• Ruschpler P, Lorenz P, Eichler W, Koczan D, Hanel C, Scholz R, . High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis. Arthritis Res Ther 2003;5:R241–52.
   Google Scholar
• Forster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 1996;87:1037–47.
   PubMed Web of Science ®Google Scholar
• Patel DD, Zachariah JP, Whichard LP. CXCR3 and CCR5 ligands in rheumatoid arthritis synovium. Clin Immunol 2001;98:39–45.
   PubMed Web of Science ®Google Scholar
• Sallusto F, Lanzavecchia A, Mackay CR. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 1998;19:568–74.
   PubMedGoogle Scholar
• Santiago B, Calonge E, Rey MJ, Gutierrez-Canas I, Izquierdo E, Usategui A, . CXCL12 gene expression is upregulated by hypoxia and growth arrest but not by inflammatory cytokines in rheumatoid synovial fibroblasts. Cytokine 2011; 53:184–90.
   PubMed Web of Science ®Google Scholar
• Blades MC, Ingegnoli F, Wheller SK, Manzo A, Wahid S, Panayi GS, . Stromal cell-derived factor 1 (CXCL12) induces monocyte migration into human synovium transplanted onto SCID mice. Arthritis Rheum 2002;46:824–36.
   PubMed Web of Science ®Google Scholar